Biocon Biologics secures market access agreements for Yesintek, a biosimilar to Stelara, for treating autoimmune diseases in ...

THE EARLY summer sun was no deterrent for those taking part in the 2025 Great Limerick Run this Sunday (May 5).

Raheen's Ava Crean, aged 19, won the women’s marathon in a time of 2:43:39. The former Crescent College Comprehensive student ...

Shares of Regeneron Pharmaceuticals Inc. REGN rallied 2.65% to $605.61 Friday, on what proved to be an all-around favorable ...

A community health initiative that began in 2007, Geisinger’s MyCode has grown into a biobank made up of data from more than ...

Shares of Regeneron Pharmaceuticals Inc. REGN slipped 1.46% to $590.00 Thursday, on what proved to be an all-around positive ...

Los Alamos High School junior Alyssa Sun (left) and sophomore Tate Plohr (right) received Grand Awards along with Aarush ...

Shares of Regeneron Pharmaceuticals are trading higher Wednesday recovering after a drop on Tuesday that followed the release ...

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported first-quarter adjusted earnings per share of $8.22, down 14% ...

Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...

Regeneron's first-quarter results missed Wall Street estimates on Tuesday due to stiff competition for its blockbuster drug ...

On an adjusted basis, Regeneron earned $8.22 per share in the first quarter, below the average analyst estimate of $8.82, ...